Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
07 01 2021
Historique:
received: 16 10 2020
revised: 04 11 2020
accepted: 17 11 2020
pubmed: 10 12 2020
medline: 16 1 2021
entrez: 9 12 2020
Statut: ppublish

Résumé

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is causing a global pandemic, and cases continue to rise. Most infected individuals experience mildly symptomatic coronavirus disease 2019 (COVID-19), but it is unknown whether this can induce persistent immune memory that could contribute to immunity. We performed a longitudinal assessment of individuals recovered from mild COVID-19 to determine whether they develop and sustain multifaceted SARS-CoV-2-specific immunological memory. Recovered individuals developed SARS-CoV-2-specific immunoglobulin (IgG) antibodies, neutralizing plasma, and memory B and memory T cells that persisted for at least 3 months. Our data further reveal that SARS-CoV-2-specific IgG memory B cells increased over time. Additionally, SARS-CoV-2-specific memory lymphocytes exhibited characteristics associated with potent antiviral function: memory T cells secreted cytokines and expanded upon antigen re-encounter, whereas memory B cells expressed receptors capable of neutralizing virus when expressed as monoclonal antibodies. Therefore, mild COVID-19 elicits memory lymphocytes that persist and display functional hallmarks of antiviral immunity.

Identifiants

pubmed: 33296701
pii: S0092-8674(20)31565-8
doi: 10.1016/j.cell.2020.11.029
pmc: PMC7682481
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Immunoglobulin G 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-183.e17

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI118803
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI106677
Pays : United States
Organisme : NIH HHS
ID : S10 OD024979
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK089507
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007140
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127726
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI150178
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002318
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI142001
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI151698
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI125378
Pays : United States

Commentaires et corrections

Type : UpdateOf
Type : UpdateOf

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests M.P., D.J.R., J.N., C.D.T., Y.C., and L.B.R. have filed a patent under the provisional serial no. 63/063,841. Other authors declare no competing interests.

Références

Nature. 2020 Aug;584(7819):120-124
pubmed: 32454512
Cell. 2020 Nov 25;183(5):1367-1382.e17
pubmed: 33160446
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Sci Transl Med. 2013 Mar 13;5(176):176ra32
pubmed: 23486778
Science. 2020 Dec 4;370(6521):1227-1230
pubmed: 33115920
Nat Protoc. 2009;4(3):372-84
pubmed: 19247287
Cell Rep. 2019 Apr 30;27(5):1446-1460.e4
pubmed: 31042472
Nat Rev Immunol. 2020 Aug;20(8):457-458
pubmed: 32636479
Science. 2020 Aug 14;369(6505):812-817
pubmed: 32434946
Nat Commun. 2021 May 19;12(1):2938
pubmed: 34011939
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608
Emerg Infect Dis. 2007 Oct;13(10):1562-4
pubmed: 18258008
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Nat Med. 2020 Sep;26(9):1428-1434
pubmed: 32661393
J Immunol. 2020 Aug 15;205(4):915-922
pubmed: 32591393
Immunity. 2011 Jan 28;34(1):108-21
pubmed: 21215658
Science. 1996 Apr 5;272(5258):54-60
pubmed: 8600537
J Immunol. 2011 Jun 15;186(12):7264-8
pubmed: 21576510
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32826322
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5545-50
pubmed: 11960012
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Nature. 1999 Oct 14;401(6754):708-12
pubmed: 10537110
MMWR Morb Mortal Wkly Rep. 2020 Oct 30;69(43):1600-1604
pubmed: 33119558
Ann N Y Acad Sci. 1996 Oct 25;797:166-76
pubmed: 8993360
Immunity. 2009 Jan 16;30(1):92-107
pubmed: 19119024
Annu Rev Immunol. 2017 Apr 26;35:255-284
pubmed: 28142324
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):E3216-24
pubmed: 23922396
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Nat Microbiol. 2020 Dec;5(12):1598-1607
pubmed: 33106674
Sci Transl Med. 2020 Aug 5;12(555):
pubmed: 32690628
Annu Rev Immunol. 2016 May 20;34:335-68
pubmed: 26907215
Cell Rep. 2016 Dec 20;17(12):3193-3205
pubmed: 28009289
Immunity. 2020 Nov 17;53(5):925-933.e4
pubmed: 33129373
Cell Mol Immunol. 2020 Jul;17(7):773-775
pubmed: 32467617
Cell. 2020 Oct 1;183(1):143-157.e13
pubmed: 32877699
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Methods Mol Biol. 2019;1956:105-125
pubmed: 30779032
Methods Mol Biol. 2012;882:569-604
pubmed: 22665256
Epidemiol Infect. 1990 Oct;105(2):435-46
pubmed: 2170159
Nat Biotechnol. 2020 Sep;38(9):1073-1078
pubmed: 32704169
PLoS One. 2017 Oct 24;12(10):e0186998
pubmed: 29065175
Immunity. 2016 Aug 16;45(2):402-14
pubmed: 27473412
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
Cell Immunol. 2017 Nov;321:26-34
pubmed: 28739077
Front Immunol. 2018 Apr 09;9:678
pubmed: 29686673
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Nat Commun. 2020 Sep 4;11(1):4420
pubmed: 32887876
N Engl J Med. 2007 Nov 8;357(19):1903-15
pubmed: 17989383
Immunol Rev. 2019 Mar;288(1):149-160
pubmed: 30874358
Clin Vaccine Immunol. 2010 Jul;17(7):1055-65
pubmed: 20463105
Sci Immunol. 2020 Oct 8;5(52):
pubmed: 33033173
Clin Infect Dis. 2021 Oct 5;73(7):e1830-e1840
pubmed: 33315061
Nat Immunol. 2013 Apr;14(4):372-9
pubmed: 23475182
Annu Rev Immunol. 2016 May 20;34:317-34
pubmed: 27168241
Biochem J. 1960 Sep;76:475-87
pubmed: 13694426
JCI Insight. 2017 Apr 20;2(8):
pubmed: 28422752
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Annu Rev Immunol. 2020 Apr 26;38:705-725
pubmed: 32340571

Auteurs

Lauren B Rodda (LB)

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.

Jason Netland (J)

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.

Laila Shehata (L)

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.

Kurt B Pruner (KB)

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.

Peter A Morawski (PA)

Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA 98101, USA.

Christopher D Thouvenel (CD)

Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Kennidy K Takehara (KK)

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.

Julie Eggenberger (J)

Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.

Emily A Hemann (EA)

Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.

Hayley R Waterman (HR)

Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA 98101, USA.

Mitchell L Fahning (ML)

Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA 98101, USA.

Yu Chen (Y)

Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Malika Hale (M)

Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Jennifer Rathe (J)

Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.

Caleb Stokes (C)

Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.

Samuel Wrenn (S)

Department of Biochemistry, University of Washington, Seattle, WA, USA, 98195 and Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.

Brooke Fiala (B)

Department of Biochemistry, University of Washington, Seattle, WA, USA, 98195 and Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.

Lauren Carter (L)

Department of Biochemistry, University of Washington, Seattle, WA, USA, 98195 and Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.

Jessica A Hamerman (JA)

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA; Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA 98101, USA.

Neil P King (NP)

Department of Biochemistry, University of Washington, Seattle, WA, USA, 98195 and Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.

Michael Gale (M)

Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.

Daniel J Campbell (DJ)

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA; Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA 98101, USA.

David J Rawlings (DJ)

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Marion Pepper (M)

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA. Electronic address: mpepper@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH